Shoulder surgery patients may keep arm movement with Just-Right painkiller dose

NCT ID NCT06587386

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested different doses of liposomal bupivacaine, a long-lasting numbing medicine, in 55 adults having shoulder surgery. The goal was to find the smallest dose that still blocks pain but lets patients move their arm. Researchers used a special method where each patient's dose depended on the previous patient's response. The results could help tailor pain management to preserve muscle function after surgery.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
liposomal bupivacaine
What this could lead to
If successful, this could help doctors use the lowest dose of this painkiller that still allows patients to move their arm after shoulder surgery.
What could go wrong
This is a small, completed dose-finding study in 55 people, so results may not apply to all patients or surgeries. The drug may still cause temporary muscle weakness or other side effects.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MOTION SICKNESS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Affiliated Hospital of Jiaxing University

    Jiaxing, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.